[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.114.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1981

Rarity of Diabetic Retinopathy in Patients With Acromegaly

Author Affiliations

From the National Eye Institute (Drs Ballintine and Foxman) and the National Institute of Arthritis, Metabolism, and Digestive Diseases (Drs Gorden and Roth), National Institutes of Health, Bethesda, Md.

Arch Intern Med. 1981;141(12):1625-1627. doi:10.1001/archinte.1981.00340130069016
Abstract

• We studied 44 acromegalic patients with the use of fluorescein angiography to detect the presence of diabetic retinopathy. We found elements of diabetic retinopathy in only one patient (2.2%). The average patient had a growth hormone concentration of 32 ng/mL (range, 1 to 275 ng/mL) for a duration of 10.5 years (range, three to 26 years). Forty-five percent (20) of our group had glucose intolerance and 14% (six) had elevated fasting blood glucose levels for an average duration of two years (range, one to four years). We conclude that diabetic retinopathy is an uncommon finding in patients with acromegaly and that fluorescein angiography does not reveal cases that were not detected by conventional funduscopic examination.

(Arch Intern Med 1981;141:1625-1627)

×